1. Japan Stocks

  2. •

    Basic Materials

  3. •

    Chemicals
Mitsubishi Chemical Group Corporation

Mitsubishi Chemical Group Corporation

4188.T
Mitsubishi Chemical Group CorporationJP flagTokyo Stock Exchange
1,099.00
JPY
+15.00
- -
1.49TMarket Cap
Mitsubishi Chemical Group Corporation
4188.T
(Tokyo Stock Exchange)

Recent

price

1,099.00

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
TTM
FRC
2,224.86
2,176.08
2,095.16
2,376
2,487.27
2,418.98
2,306.04
2,587.58
2,700.63
2,521.52
2,293.63
2,798.81
3,259.66
3,083.99
3,097.52
- -
1,572.66
Revenue per Share
58.72
24.07
12.61
21.9
41.4
35.06
106.73
147.14
119.22
38.08
-5.32
124.68
67.85
84.07
31.64
- -
36.82
Basic EPS, GAAP
121.84
69.17
48.32
28.48
115.03
55.08
130.37
117.89
130.09
152.06
147.94
62.78
52.18
134.03
- -
- -
85.23
Free Cash Flow per Basic Share
8.69
10.01
11.01
12.02
12
14
16.01
27
37.18
40
24
27
30
31
- -
- -
16
Dividend per Share
352.64
355.95
358.91
369.16
430.47
451.19
554.21
699.59
790.34
789.63
781.6
889.32
928.82
987.74
993.54
- -
1,000.64
Book Value per Share
623.29
635.42
649.94
691.54
788
773.32
791.03
861.6
568.39
227.81
312.58
485.66
563.8
675.93
713.29
- -
698.45
Tangible Book Value per Share
1,423
1,474
1,474
1,473
1,470
1,465
1,464
1,439
1,422
1,420
1,420
1,421
1,422
1,423
1,423
1,371
1,423
Basic Weighted Avg Shares
3,166,771
3,208,168
3,088,577
3,498,834
3,656,278
3,543,352
3,376,057
3,724,406
3,840,341
3,580,510
3,257,535
3,976,948
4,634,532
4,387,218
4,407,405
- -
2,237,320
Sales/Revenue/Turnover
7.15
4.07
2.92
3.16
4.53
7.19
7.45
8.84
6.98
3.66
0.98
7.09
3.69
5.78
4.28
- -
5.33
Operating Margin (%)
158,405
157,979
141,382
146,279
172,397
182,656
174,040
178,895
199,332
239,824
243,793
251,469
269,616
275,436
- -
- -
139,805
Depreciation Expense
83,581
35,486
18,596
32,248
60,859
51,358
156,259
211,788
169,530
54,077
-7,557
177,162
96,461
119,596
45,020
- -
52,384
Net Income, GAAP
27.7
41.68
48.41
48.32
41.76
29.3
17.19
19.68
24.78
42.9
30.95
27.88
19.3
25.82
29.9
- -
23.64
Effective Tax Rate (%)
2.64
1.11
0.6
0.92
1.66
1.45
4.63
5.69
4.41
1.51
-0.23
4.45
2.08
2.73
1.02
- -
2.34
Profit Margin (%)
251,085
307,580
202,882
304,044
241,372
415,015
618,476
604,771
128,541
112,782
305,028
566,823
485,788
466,724
561,402
- -
513,606
Working Capital
827,977
767,798
653,222
692,729
859,216
872,870
1,116,005
1,025,268
1,138,108
1,555,947
1,696,029
1,748,756
1,642,325
1,595,704
1,612,920
- -
1,558,863
LT Debt
1,114,003
1,144,954
1,203,316
1,314,870
1,602,380
1,596,151
1,698,197
1,919,490
2,025,854
1,450,829
1,571,148
1,844,319
1,988,469
2,275,495
2,284,569
- -
2,257,968
Total Equity
6.61
3.19
1.96
2.27
3.31
5.58
6.29
7.57
5.12
1.86
0.57
5.1
3.32
4.3
2.98
- -
2.02
Return on Invested Capital (%)
2.56
0.28
0.1
0.59
1.4
0.54
3.7
5.14
3.78
1
-0.59
4.23
2.12
2.32
0.57
- -
0.99
Return on Capital (%)
17.95
6.91
3.53
6.01
10.35
7.94
21.23
23.3
15.91
4.82
-0.68
14.93
7.47
8.78
3.19
- -
3.75
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
Mar'24
Jun'25
Sep'25
ST Debt
605,307
- -
533,855
LT Borrowings
1,595,704
- -
1,558,863
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,423
- -
1,423
Market Capitalization
1,302,913
1,270,523
1,307,262

Working Capital

FRC

•

in mil. unless spec.
Mar'24
Jun'25
Sep'25
Total Current Assets
2,191,636
- -
2,152,336
Cash, Cash Equivalents & STI
377,728
- -
352,092
Accounts Receivable, Net
852,353
- -
761,072
Inventories
799,249
- -
808,784
Total Current Liabilities
1,724,912
- -
1,638,730
Payables & Accruals
- -
- -
- -
ST Debt
605,307
- -
533,855
Deferred Revenue
- -
- -
- -

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
1,061,242
1,088,656
1,095,242
1,142,078
4,387,218
2025
- -
- -
- -
- -
4,407,405
2026
- -
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
29.91
17.35
25.77
- -
84.07
2025
- -
- -
- -
- -
31.64
2026
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
15
- -
16
- -
31
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Hangzhou Greenda Electronic Materials Co., Ltd. (603931.SS)
FSPG Hi-Tech Co. Ltd. (000973.SZ)
Adkins Energy LLC (ADKIL)
GRIPM Advanced Materials Co., Ltd. (688456.SS)
Polymeric Resources Corporation (PLYR)
Valiant Organics Limited (VALIANTORG.BO)
Business
Mitsubishi Chemical Group Corporation (4188.T), a leading global chemicals company headquartered in Tokyo, Japan, and founded in 2005 through the merger of Mitsubishi Chemical Corporation and Mitsubishi Pharma Corporation, develops and markets a broad portfolio of advanced materials and chemicals across multiple segments including Specialty Materials, Industrial Gases, Health Care, MMA, and Basic Materials; core products and services encompass performance polymers such as soarnol and gohsenol, engineering plastics, sustainable polymers, coating materials, packaging films, polyester films, carbon fiber and composite materials, semiconductor and battery materials, ethical pharmaceuticals, methyl methacrylate (MMA) and polymethyl methacrylate (PMMA), basic petrochemicals, polyolefins, industrial gases, and engineered solutions for automotive, electronics, healthcare, and environmental applications. The company operates worldwide with key facilities in Japan, Europe, North America, and Asia, serving industries ranging from aerospace and automotive to electronics, energy, and healthcare through subsidiaries like Mitsubishi Chemical Corporation and advanced materials divisions focused on high-performance thermoplastics and composites. Recent developments include the February 2025 agreement to sell its pharmaceutical business, Mitsubishi Tanabe Pharma, to Bain Capital for approximately $3.37 billion to sharpen focus on core chemical operations; a November 2024 investment via its Diamond Edge Ventures arm in Boston Materials' $13.5 million funding round to expand carbon fiber applications in semiconductors and aerospace; an August 2025 binding offtake agreement with NextSource Materials for up to 9,000 tonnes per annum of anode active material (AAM) to supply North American EV manufacturers from a planned Middle East facility; and a November 2025 sales and purchase agreement between subsidiary Mitsubishi Gas Chemical and Transition Industries for ultra-low carbon methanol starting in 2029, supporting decarbonization efforts in Asia.